|
|
PAREXEL International Corporation - Comparative Business Analysis Snapshot
Business Description
PAREXEL International Corporation. The Group's principal activities are to provide biopharmaceutical services. The Group operates in three business segments: Clinical Research Services; PAREXEL Consulting and Medical Communications Services and Perceptive Informatics Inc. Clinical Research Services Segment provide clinical trials management and biostatistics, data management and clinical pharmacology services. PAREXEL Consulting and Marketing Services Segment provide technical expertise in disciplines such as drug development, regulatory affairs and biopharmaceutical process and management consulting. Perceptive Segment provides information technology solutions designed to improve clients' product development processes. The Group operates in the United States, Europe, Africa, Asia and other foreign countries. On 14-Aug-2009, the Group acquired ClinPhone plc.
Competitor Analysis
This analysis compares PAREXEL International Corporation with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
